137 related articles for article (PubMed ID: 33581650)
1. Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function.
Song X; Gao J; Liu H; Liu X; Tang K
Biomed Pharmacother; 2021 May; 137():111289. PubMed ID: 33581650
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
3. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Xiang L; Liu A; Xu G
Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.
Wolf VL; Taylor EB; Ryan MJ
Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322
[TBL] [Abstract][Full Text] [Related]
5. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X
Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258
[TBL] [Abstract][Full Text] [Related]
6. Aconitine: A potential novel treatment for systemic lupus erythematosus.
Li X; Gu L; Yang L; Zhang D; Shen J
J Pharmacol Sci; 2017 Mar; 133(3):115-121. PubMed ID: 28302448
[TBL] [Abstract][Full Text] [Related]
7. [Study on experimental systemic lupus erythematosus mouse model induced by pristane].
Li JZ; Ding J; Merim B; Li HW; Zhang Y; Shen H; Chen XJ; Wang SJ; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):119-22. PubMed ID: 21315035
[TBL] [Abstract][Full Text] [Related]
8. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus.
Pannu N; Bhatnagar A
Immunobiology; 2020 Jan; 225(1):151871. PubMed ID: 31780314
[TBL] [Abstract][Full Text] [Related]
10. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
11. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation.
Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201
[TBL] [Abstract][Full Text] [Related]
12. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
13. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
15. Effect of Xuebijing injection on systemic lupus erythematosus in mice.
Wang YB; Wang Q; Yao YM; Sheng ZY; Liu YF
Chin J Integr Med; 2013 Sep; 19(9):675-82. PubMed ID: 23975132
[TBL] [Abstract][Full Text] [Related]
16. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
Moon JS; Mun CH; Kim JH; Cho JY; Park SD; Park TY; Shin JS; Ho CC; Park YB; Ghosh S; Bothwell ALM; Lee SW; Lee SK
Kidney Int; 2018 May; 93(5):1118-1130. PubMed ID: 29409726
[TBL] [Abstract][Full Text] [Related]
17. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
18. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
[TBL] [Abstract][Full Text] [Related]
19. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus.
Calvani N; Satoh M; Croker BP; Reeves WH; Richards HB
Kidney Int; 2003 Sep; 64(3):897-905. PubMed ID: 12911539
[TBL] [Abstract][Full Text] [Related]
20. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.
Liu X; Jiao Y; Cui B; Gao X; Xu J; Zhao Y
Lupus; 2016 Oct; 25(11):1180-9. PubMed ID: 27125291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
